Results 191 to 200 of about 104,921 (341)

Botulinum toxin on a mission to erase keloids: does the dream come true? [PDF]

open access: yesPostepy Dermatol Alergol
Fratczak A   +4 more
europepmc   +1 more source

Botulinum toxin

open access: yesIndian Journal of Dermatology, Venereology and Leprology, 2008
openaire   +2 more sources

Defining Pharyngeal and Upper Esophageal Sphincter Disorders on High‐Resolution Manometry‐Impedance: The Leuven Consensus

open access: yesNeurogastroenterology &Motility, EarlyView.
The Leuven Consensus provides a classification scheme for the diagnosis of pharyngeal and upper esophageal sphincter (UES) motor disorders using metrics derived from pharyngeal high‐resolution manometry‐impedance (P‐HRM‐I). These recommendations complement routine instrumental investigations and provide a standardized process, criteria, and ...
Taher I. Omari   +25 more
wiley   +1 more source

Gut mucin fucosylation dictates the entry of botulinum toxin complexes. [PDF]

open access: yesNat Commun
Amatsu S   +12 more
europepmc   +1 more source

Referred Pain Manifestation and Its Impact on Patients With Temporomandibular Disorder

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective To investigate whether a higher number of sites eliciting referred pain upon palpation is associated with greater impairment in biopsychosocial aspects in TMD patients and identify variables that predict increased referred pain. Methods This cross‐sectional study analyzed data from 77 women with myalgia, assessing the number of sites
Beatriz Amaral de Lima‐Netto   +5 more
wiley   +1 more source

Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine [PDF]

open access: gold, 2018
Ioana Ion   +7 more
openalex   +1 more source

Adverse Events in Nonsurgical Facial Aesthetic Procedures: A Systematic Review and Meta‐Analysis

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective To determine the prevalence and clinical profile of treatment‐related adverse events (TRAE) associated with: (1) botulinum toxin in the upper face; (2) hyaluronic acid fillers in the lower face and nasolabial folds; and (3) nonsurgical facelifts with absorbable threads. Methods Searches were conducted in five electronic databases and
Vitória Maria Sousa Cruz   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy